Leandro Gonzaga de Oliveira
Research Subjects
Leandro Gonzaga de Oliveira has a total of 12 co-authors. Here are the top co-authors by number of shared publications:
- Ana Paula Fernandes
Centro de Tecnologia de Vacinas, Universidade Federal de Minas Gerais, Belo Horizonte, Brazil
1 shared publication - Antonio Carlos da Silva Junior
Universidade Estadual Paulista “Júlio de Mesquita Filho”, Brazil
1 shared publication - Caroline Dohanik da Silva
Department of Pharmaceutical Products Faculty of Pharmacy Universidade Federal de Minas Gerais Belo Horizonte 31270-901 Minas Gerais Brazil ufmg.br
1 shared publication - Dagoberto Martins
Department of Plant Production, School of Agricultural and Veterinary Sciences, São Paulo State University, Jaboticabal 14884-900, Brazil
1 shared publication - Dennis Christensen
Department of Infectious Disease Immunology Statens Serum Institut Artillerivej 5 Copenhagen S 2300 Denmark
1 shared publication - Diego dos Santos Ferreira
Department of Pharmaceutical Products Faculty of Pharmacy Universidade Federal de Minas Gerais Belo Horizonte 31270-901 Minas Gerais Brazil ufmg.br
1 shared publication
Latest Publications
- Open Access
- 1 January 2026
- Published by Wiley in Journal of Immunology Research
- Vol. 2026 (1)
Preclinical Safety and Immunogenicity Characterization of Emulsivant 70: A Promising Candidate Adjuvant for Emulsified Veterinary Vaccines
Adjuvants are usually a fundamental part of a vaccine formulation due to their ability to increase immunogenicity, but their safety and efficacy must be established in preclinical studies. In this sense, we evaluated Emulsivant 70, a new ready‐to‐use adjuvant based on water‐in‐oil (W/O) emulsion for veterinary vaccines. Its performance was compared with the commercial adjuvant Montanide ISA 70 in mice immunized with tetanus toxoid (TT) and inactivated influenza PR8. No substantial changes in renal or hepatic biochemical markers (urea, creatinine, alanine aminotransferase [ALT], and aspartate aminotransferase [AST]) were observed for any formulation. Emulsivant 70 induced lower reactogenicity at the injection site than Montanide ISA 70. Both adjuvants enhanced IgG and IgG1 responses, but Emulsivant 70 promoted a faster increase in total IgG for both antigens. IFN‐γ levels increased similarly across adjuvanted groups. Following the influenza A challenge, all PR8‐immunized were fully protected. Overall, this study provides the first evidence that Emulsivant 70 is a safe adjuvant that elicits less local reactivity and achieves immunogenicity comparable to Montanide ISA 70, while inducing a faster humoral response. These findings support Emulsivant 70 as a promising alternative for the development of veterinary vaccines.
- 1 January 2026
- Published by Wiley in Journal of Immunology Research
- Vol. 2026 (1)
Open AccessPreclinical Safety and Immunogenicity Characterization of Emulsivant 70: A Promising Candidate Adjuvant for Emulsified Veterinary Vaccines
Adjuvants are usually a fundamental part of a vaccine formulation due to their ability to increase immunogenicity, but their safety and efficacy must be established in preclinical studies. In this sense, we evaluated Emulsivant 70, a new ready‐to‐use adjuvant based on water‐in‐oil (W/O) emulsion for veterinary vaccines. Its performance was compared with the commercial adjuvant Montanide ISA 70 in mice immunized with tetanus toxoid (TT) and inactivated influenza PR8. No substantial changes in renal or hepatic biochemical markers (urea, creatinine, alanine aminotransferase [ALT], and aspartate aminotransferase [AST]) were observed for any formulation. Emulsivant 70 induced lower reactogenicity at the injection site than Montanide ISA 70. Both adjuvants enhanced IgG and IgG1 responses, but Emulsivant 70 promoted a faster increase in total IgG for both antigens. IFN‐γ levels increased similarly across adjuvanted groups. Following the influenza A challenge, all PR8‐immunized were fully protected. Overall, this study provides the first evidence that Emulsivant 70 is a safe adjuvant that elicits less local reactivity and achieves immunogenicity comparable to Montanide ISA 70, while inducing a faster humoral response. These findings support Emulsivant 70 as a promising alternative for the development of veterinary vaccines.
- Open Access
- 1 January 2022
- Published by FapUNIFESP (SciELO) in Arquivos do Instituto Biológico
- Vol. 89
Selectivity of herbicides applied to Brazilian tree species at post-emergence
- 1 January 2022
- Published by FapUNIFESP (SciELO) in Arquivos do Instituto Biológico
- Vol. 89
Open AccessSelectivity of herbicides applied to Brazilian tree species at post-emergence